Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

Treatment with hypomethylating agents (HMAs) improves overall survival (OS) in patients who achieve a response of stable disease (SD) or better (complete remission [CR], partial remission [PR], or hematologic improvement [HI]). It is not well established if patients who achieve SD at 4–6 months of t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Leuk Res
Main Authors: Nazha, Aziz, Sekeres, Mikkael A., Garcia-Manero, Guillermo, Barnard, John, Al Ali, Najla H., Roboz, Gail J., Steensma, David P., DeZern, Amy E., Zimmerman, Cassie, Jabbour, Elias J., Zell, Katrina, List, Alan F., Kantarjian, Hagop M., Maciejewski, Jaroslaw P., Komrokji, Rami S.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986515/
https://ncbi.nlm.nih.gov/pubmed/26777537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2015.12.007
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker